PSSI has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
PSSI has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | 0.359 |
PSSI's Cash to Debt is ranked higher than
52% of the 48 Companies in the Global Medical Distribution industry. ( Industry Median: 0.95 vs. PSSI: 0.359 ) |
PSSI'
s 10-Year Cash to Debt Range
Min: 0.1 Max: 0.63 Current: 0.36 |
| Equity to Asset | 0.113 |
PSSI's Equity to Asset is ranked higher than
60% of the 48 Companies in the Global Medical Distribution industry. ( Industry Median: 0.40 vs. PSSI: 0.113 ) |
PSSI'
s 10-Year Equity to Asset Range
Min: 0.11 Max: 0.44 Current: 0.11 |
| Interest Coverage | 6.7 |
PSSI's Interest Coverage is ranked higher than
52% of the 48 Companies in the Global Medical Distribution industry. ( Industry Median: 18.90 vs. PSSI: 6.7 ) |
PSSI'
s 10-Year Interest Coverage Range
Min: 2 Max: 20 Current: 6.7 |
| F-Score: 6 |
|
| Z-Score: 4.2 |
|
| M-Score: -2.88 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | 6.30 |
PSSI's Operating margin (%) is ranked higher than
77% of the 48 Companies in the Global Medical Distribution industry. ( Industry Median: 3.60 vs. PSSI: 6.30 ) |
PSSI'
s 10-Year Operating margin (%) Range
Min: -1.5 Max: 6.6 Current: 6.3 |
| Net-margin (%) | 3.5 |
PSSI's Net-margin (%) is ranked higher than
77% of the 48 Companies in the Global Medical Distribution industry. ( Industry Median: 2.30 vs. PSSI: 3.5 ) |
PSSI'
s 10-Year Net-margin (%) Range
Min: -4.6 Max: 3.7 Current: 3.5 |
| ROE (%) | 19.2 |
PSSI's ROE (%) is ranked higher than
79% of the 48 Companies in the Global Medical Distribution industry. ( Industry Median: 11.20 vs. PSSI: 19.2 ) |
PSSI'
s 10-Year ROE (%) Range
Min: -25 Max: 19.2 Current: 19.2 |
| ROA (%) | 6.4 |
PSSI's ROA (%) is ranked higher than
79% of the 48 Companies in the Global Medical Distribution industry. ( Industry Median: 3.90 vs. PSSI: 6.4 ) |
PSSI'
s 10-Year ROA (%) Range
Min: -12.2 Max: 8 Current: 6.4 |
| ROC (Joel Greenblatt) (%) | 31.50 |
PSSI's ROC (Joel Greenblatt) (%) is ranked higher than
69% of the 48 Companies in the Global Medical Distribution industry. ( Industry Median: 26.40 vs. PSSI: 31.50 ) |
PSSI'
s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -7.8 Max: 31.9 Current: 31.5 |
| Revenue Growth (%) | 5.5 |
PSSI's Revenue Growth (%) is ranked higher than
87% of the 48 Companies in the Global Medical Distribution industry. ( Industry Median: 0.90 vs. PSSI: 5.5 ) |
PSSI'
s 10-Year Revenue Growth (%) Range
Min: -9.4 Max: 9.8 Current: 5.5 |
| EBITDA Growth (%) | 11.4 |
PSSI's EBITDA Growth (%) is ranked higher than
92% of the 48 Companies in the Global Medical Distribution industry. ( Industry Median: 0.70 vs. PSSI: 11.4 ) |
PSSI'
s 10-Year EBITDA Growth (%) Range
Min: -17.2 Max: 24.6 Current: 11.4 |
| EPS Growth (%) | 10.2 |
PSSI's EPS Growth (%) is ranked higher than
85% of the 48 Companies in the Global Medical Distribution industry. ( Industry Median: 0.00 vs. PSSI: 10.2 ) |
PSSI'
s 10-Year EPS Growth (%) Range
Min: 9.7 Max: 16.3 Current: 10.2 |
| Steven Cohen 72,173 sh (New) Paul Tudor Jones 305,000 sh (+2672.73%) Jim Simons 243,056 sh (+633.07%) Joel Greenblatt 100,727 sh (+119.18%) | Mario Gabelli 58,000 sh (unchged) | Ken Fisher 920,990 sh (-1.14%) |
| Manning & Napier Advisors, Inc 418,023 sh (New) Steven Cohen 456,554 sh (+532.58%) Ken Fisher 1,855,895 sh (+101.51%) | Mario Gabelli 58,000 sh (unchged) | Paul Tudor Jones Sold Out Jim Simons 117,856 sh (-51.51%) Joel Greenblatt 15,194 sh (-84.92%) |
| Mario Gabelli 351,030 sh (+505.22%) Jim Simons 451,256 sh (+282.89%) | Jeremy Grantham 956,612 sh (unchged) | Ken Fisher Sold Out Steven Cohen Sold Out Manning & Napier Advisors, Inc Sold Out Joel Greenblatt Sold Out |
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| Mario Gabelli | 2012-12-31 | Add 505.22% | 0.06% | $21.6 - $28.87 | $ 22.4 | -16% | 351030 | |
| Joel Greenblatt | 2012-12-31 | Sold Out | 0.02% | $21.6 - $28.87 | $ 22.4 | -16% | 0 | |
| Joel Greenblatt | 2012-09-30 | Reduce -84.92% | 0.14% | $19.88 - $23.27 | $ 22.4 | 3% | 15194 | |
| Joel Greenblatt | 2012-06-30 | Add 119.18% | 0.09% | $18.9 - $25.68 | $ 22.4 | 3% | 100727 | |
| Joel Greenblatt | 2012-03-31 | Reduce -20.33% | 0.03% | $22.93 - $25.86 | $ 22.4 | -3% | 45957 | |
| Joel Greenblatt | 2011-12-31 | Add 57.51% | 0.06% | $18.79 - $24.66 | $ 22.4 | 0% | 57683 | |
| Joel Greenblatt | 2011-09-30 | Add 117.41% | 0.06% | $19.48 - $28.76 | $ 22.4 | -6% | 36621 | |
| Joel Greenblatt | 2011-03-31 | New Buy | 0.15% | $22.5 - $27.04 | $ 22.4 | -9% | 18754 | |
| Mario Gabelli | 2011-03-31 | Reduce -43.14% | 0.01% | $22.5 - $27.04 | $ 22.4 | -9% | 58000 | |
| George Soros | 2010-12-31 | Sold Out | 0.1% | $20.6 - $23.65 | $ 22.4 | 2% | 0 | |
| George Soros | 2010-09-30 | New Buy | 0.1% | $18.27 - $21.51 | $ 22.4 | 14% | 325000 | |
| Mario Gabelli | 2010-09-30 | Add 75.86% | $18.27 - $21.51 | $ 22.4 | 14% | 102000 | ||
| Mario Gabelli | 2010-06-30 | Reduce -44.23% | $21.39 - $24.16 | $ 22.4 | -3% | 58000 | ||
| Ron Baron | 2010-03-31 | Sold Out | 0.11% | $18.58 - $23.96 | $ 22.4 | 3% | 0 |
More recent guru trades are included for Premium Members only!!| vs
industry |
vs
history |
||
|---|---|---|---|
| P/E(ttm) | 11.00 |
PSSI's P/E(ttm) is ranked higher than
80% of the 41 Companies in the Global Medical Distribution industry. ( Industry Median: 19.90 vs. PSSI: 11.00 ) |
PSSI'
s 10-Year P/E(ttm) Range
Min: 8.62 Max: 34.81 Current: 11 |
| P/B | 2.04 |
PSSI's P/B is ranked higher than
52% of the 44 Companies in the Global Medical Distribution industry. ( Industry Median: 2.25 vs. PSSI: 2.04 ) |
PSSI'
s 10-Year P/B Range
Min: 0.41 Max: 4.2 Current: 2.04 |
| P/S | 0.39 |
PSSI's P/S is ranked higher than
78% of the 45 Companies in the Global Medical Distribution industry. ( Industry Median: 0.48 vs. PSSI: 0.39 ) |
PSSI'
s 10-Year P/S Range
Min: 0.1 Max: 0.88 Current: 0.39 |
| PFCF | 7.82 |
PSSI's PFCF is ranked higher than
68% of the 38 Companies in the Global Medical Distribution industry. ( Industry Median: 14.53 vs. PSSI: 7.82 ) |
PSSI'
s 10-Year PFCF Range
Min: 4.87 Max: 1308 Current: 7.82 |
| EV-to-EBIT | 12.76 |
PSSI's EV-to-EBIT is ranked higher than
85% of the 41 Companies in the Global Medical Distribution industry. ( Industry Median: 11.30 vs. PSSI: 12.76 ) |
PSSI'
s 10-Year EV-to-EBIT Range
Min: 8.3 Max: 36.7 Current: 12.76 |
| PEG | 0.68 |
PSSI's PEG is ranked higher than
70% of the 23 Companies in the Global Medical Distribution industry. ( Industry Median: 1.62 vs. PSSI: 0.68 ) |
PSSI'
s 10-Year PEG Range
Min: 0.68 Max: 1.72 Current: 0.68 |
| Shiller P/E | 13.67 |
PSSI's Shiller P/E is ranked lower than
100% of the Companies in the Global Medical Distribution industry. ( Industry Median: vs. PSSI: 13.67 ) |
PSSI'
s 10-Year Shiller P/E Range
Min: 13.67 Max: 354.33 Current: 13.67 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price/Net Current Asset Value | 3.9 |
PSSI's Price/Net Current Asset Value is ranked higher than
86% of the 43 Companies in the Global Medical Distribution industry. ( Industry Median: 3.50 vs. PSSI: 3.9 ) |
PSSI'
s 10-Year Price/Net Current Asset Value Range
Min: 1.3 Max: 5.7 Current: 3.9 |
| Price/Tangible Book | 8.6 |
PSSI's Price/Tangible Book is ranked higher than
82% of the 33 Companies in the Global Medical Distribution industry. ( Industry Median: 2.50 vs. PSSI: 8.6 ) |
PSSI'
s 10-Year Price/Tangible Book Range
Min: 1.5 Max: 10.1 Current: 8.6 |
| Price/DCF (Projected) | 0.9 | ||
| Price/Median PS Value | 0.9 |
PSSI's Price/Median PS Value is ranked higher than
83% of the 42 Companies in the Global Medical Distribution industry. ( Industry Median: 1.10 vs. PSSI: 0.9 ) |
PSSI'
s 10-Year Price/Median PS Value Range
Min: 0.3 Max: 1.4 Current: 0.9 |
| Price/Peter Lynch Fair Value | 1 |
PSSI's Price/Peter Lynch Fair Value is ranked lower than
138% of the 13 Companies in the Global Medical Distribution industry. ( Industry Median: 1.30 vs. PSSI: 1 ) |
PSSI'
s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.1 Max: 1.3 Current: 1 |
| Price/Graham Number | 2.5 |
PSSI's Price/Graham Number is ranked higher than
83% of the 35 Companies in the Global Medical Distribution industry. ( Industry Median: 1.70 vs. PSSI: 2.5 ) |
PSSI'
s 10-Year Price/Graham Number Range
Min: 1.4 Max: 3.1 Current: 2.5 |
| Earnings Yield (Greenblatt) | 7.80 |
PSSI's Earnings Yield (Greenblatt) is ranked higher than
87% of the 48 Companies in the Global Medical Distribution industry. ( Industry Median: 8.20 vs. PSSI: 7.80 ) |
PSSI'
s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.7 Max: 12 Current: 7.8 |
| Forward Rate of Return (Yacktman) | 23.55 |
PSSI's Forward Rate of Return (Yacktman) is ranked higher than
81% of the 48 Companies in the Global Medical Distribution industry. ( Industry Median: 0.00 vs. PSSI: 23.55 ) |
PSSI'
s 10-Year Forward Rate of Return (Yacktman) Range
Min: -3.1 Max: 30.1 Current: 23.55 |
| Industry: | Medical Distribution |
|---|---|
| Compare: | ABC, MCK, CAH, SHTDF, HSIC |